Chairman Albert Bowers to resume position of president following announced early retirement of Richard Rogers (effective Dec. 31). Bowers was president of Syntex from 1976 to 1982. The company reported that Bowers "expects to announce some restructuring of reporting relationships by the end of October." Rogers "has expressed an interest in spending more time with his wife, six daughters, five sons-in-law and soon-to-be nine grandchildren, and in writing, painting, woodworking, hunting and fishing . . . He has made a commitment to become deeply-involved in two churches which mean a great deal to his family," Bowers said.
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.